Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Dual 5-LO and COX-2 inhibitors for inflammatory disorders

Sep. 3, 1998

Zeneca patents new peptides for autoimmune/inflammatory disorders

Sep. 2, 1998

New treatment for osteoarthritis pain now available in the U.K.

Aug. 31, 1998

New agent for the prevention of osteoarthritis identified at Roche Bioscience

Aug. 27, 1998

MMP inhibitors under investigation at Pharmacia & Upjohn

Aug. 27, 1998

FDA gives priority review status to COX-2 inhibitor

Aug. 27, 1998

Selective MMP-3 inhibitor PS-508 described at ACS meeting

Aug. 26, 1998

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

FDA advisory committee meeting scheduled to review Enbrel BLA

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...